Enovis Corporation (NYSE:ENOV) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Hello, and welcome to Enovis First Quarter 2025 Earnings Call. [Operator Instructions] Thank you.
Enovis Corp (ENOV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 2,453,265 | $55,811,779 | 0.59% | |
| 2. | Hood River Capital Management David Swank | 1,756,669 | $39,964,220 | +2% | 0.4% |
| 3. | 30,864,000 | $29,904,385 | 0.51% | ||
| 4. | 24,500,000 | $23,774,212 | 0.76% | ||
| 5. | 21,000,000 | $20,722,339 | +20% | 1.63% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.74 | 1,000 | $23,740.00 | 48,640 | 2026-03-13 | Filing | |
| $23.93 | 1,000 | $23,930.00 | 47,640 | 2026-03-10 | Filing | |
| $23.39 | 1,000 | $23,390.00 | 46,640 | 2026-03-09 | Filing | |
| $24.48 | 500 | $12,240.00 | 45,640 | 2026-03-06 | Filing | |
| $24.28 | 250 | $6,070.00 | 45,140 | 2026-03-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.22 | 333 | $9,064.26 | 0 | 2025-12-09 | Filing | |
| $27.18 | 333 | $9,050.94 | 0 | 2025-12-09 | Filing | |
| $27.21 | 333 | $9,060.93 | 0 | 2025-12-09 | Filing | |
| $27.21 | 666 | $18,121.86 | 160,449 | 2025-12-09 | Filing | |
| $59.18 | 174 | $10,297.32 | 4,218 | 2023-08-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,936,469 | $226,054,672 | 0% | |
| 2. | 4,768,921 | $108,492,953 | 0.06% | |
| 3. | 106,748,000 | $103,394,464 | 0.58% | |
| 4. | 106,093,000 | $102,618,454 | 2.37% | |
| 5. | 3,808,629 | $86,646,310 | 0% |
News See All
10 Best Medical Stocks to Buy Under $30
On April 28, Reuters reported that the US Food and Drug Administration has introduced a new pilot program that would allow the agency to monitor clinical trial data in real time.
Enovis Corporation (NYSE:ENOV) Q4 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Enovis Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Evercore ISI Bullish on Enovis (ENOV) Despite Weak Share Price Momentum
Enovis Corporation (NYSE:ENOV) underwent a challenging period in 2025 amid macro headwinds.
14 Oversold Value Stocks to Invest in Right Now
On January 13, 2026, Ari Wald, Head of Technical Analysis at Oppenheimer, spoke with CNBC, noting that technical indicators suggest U.S.
Enovis Corporation (ENOV): Orthopedic Innovation and Growth Potential Drive Analyst Confidence
Enovis Corporation (NYSE:ENOV) is one of the best cheap stocks poised to skyrocket. On January 6, BTIG initiated coverage of Enovis Corporation (NYSE:ENOV) with a Buy rating and a $41 price target.
10 Best Cheap Stocks That Will Skyrocket
Rotation into cheap stocks is becoming increasingly popular as investors explore ways to circumvent premium valuations in equity markets.
Enovis Corporation (ENOV): A Bull Case Theory
We came across a bullish thesis on Enovis Corporation on Value investing subreddit by TheBestOfAllTylers. In this article, we will summarize the bulls’ thesis on ENOV.
Canaccord Genuity Slashes PT on Enovis Corporation (ENOV) to $50 From $58
Enovis Corporation (NYSE:ENOV) is one of the best small cap stocks to buy with huge upside potential.
12 Small Cap Stocks to Buy with Huge Upside Potential
Talking about rotation in the market, she expects the trend to continue for a while, with the capital basically moving from the high multiple mega cap winners towards small caps, cyclicals, and the international...
Hedge Fund Resource Center